TCT-329 Cardiovascular Imaging Radiation in Coronary Artery Disease: Is It a Real Concern?  by Krepsky, Ana M. et al.
TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM www.jacctctabstracts2013.com
P
O
S
T
E
R
SConclusions: Combination of SYNTAX with STS-risk score inﬂuences therapeutic
decision-making in routine practice. A MHT approach resulted in recommendation for
surgical revascularization in patients with low-STS risk regardless of SYNTAX score.
Conversely, PCI was recommended more frequently in patients with high STS-risk
regardless of SYNTAX. Further studies should focus on the clinical outcomes of these
revascularization strategies.
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In-Hospital and Long-Term Prognosis of Anemia on Admission in Patients
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Background: Anemia is common before percutaneous coronary intervention (PCI).
Numerous studies have shown the prognostic value of anemia in patients with acute
coronary syndrome (ACS). Nevertheless, few studies have investigated the long-term
impact and in-hospital prognosis of anemia on admission in patients undergoing PCI
and constitutes the aim of this study.
Methods: We performed a single-center observational study with prospective follow-
up of 759 consecutive patients undergoing PCI between 2007 and 2011. Anemia was
deﬁned according to OMS’s criteria (hemoglobin <13 g /dl in men and <12 g /dl in
women). We evaluated the relationship between anemia on admission with cardio-
vascular events and long-term mortality (mean follow-up 26.5  14.4 months).
Results: Anemia on admission was observed in 226 (23.5%) patients. Patients with
anemia on admission were older (72  10 vs. 64  11 years, p <0.001), female
(23.5 vs. 15.2%, p ¼ 0.006) diabetic (47.3 vs. 31.5%, p <0.001) and hypertense
(76.1 vs. 63.4%, p ¼ 0.001). Most often patients were previously treated with anti-
coagulants (14.2 vs. 7.3%, p ¼ 0.003) antiplatelets (58.4 vs. 44.1%, p <0.001) had
increased prevalence of acute myocardial infarction (AMI) on admission (59.7 vs.
49.2%, p ¼ 0.008), lower creatinine clearance (66.5  29.6 78.9  23 ml/min/
1.73m2, p <0.001) and higher levels of C reactive protein (35.5  54.5 front 13.2 
25.6 mg/l, p <0.001). While being hospitalized patients had a higher incidence of
contrast-induced acute kidney injury (15 vs. 6%, p <0.001), bleeding complications
(19.5 vs. 8.6%, p <0.001), need for transfusion (6.6 vs. 6%, p <0.001) and mortality
(5.3 vs. 1.5%, p ¼ 0.003). During long-term follow-up they had more readmissions
(59.7 vs. 47.7%, p ¼ 0.002), AMI with ST segment elevation (4.5 vs. 1.7%, p ¼
0.027), stroke (5.8 vs. 2.1%, p ¼ 0.008) cardiac mortality (8 vs. 2.8%, p <0.001) and
all cause mortality (20.4 vs. 4.9%, p <0.001). Cox regression analysis showed that
anemia was an independent predictor of all cause mortality (adjusted hazard ratio ¼
2.1, CI 95% 1.1-4.1, P ¼ 0.028)
Conclusions: Patients with anemia on admission are numerous and have both poorer
in hospital and long term prognosis and increased long-term mortality.
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Background: Local paclitaxel delivery to coronary arteries by application of a drug-
coated balloon (DCB) has been shown to reduce in-stent restenosis (ISR) and lateB104 JACC Vol 62/18/Suppl B j October 27–Novemlumen loss in de novo lesions of small coronary arteries in comparison to other forms
of PCI. While inherent healing processes after plane PTCA have led to a high rate of
restenosis due to recoil and intimal proliferation, we observed an unanticipated
decrease in residual stenosis while following patients after application of DCBs. It was
the aim of this study to systematically study and quantify this phenomenon.
Methods: We evaluated 58 native coronary artery lesions mainly of small vessels (12
RCA, 21 LAD and 25 CX) in 56 consecutive patients directly after DCB intervention
and 42 months thereafter by quantitative coronary angiography. Treatment of ISR
and left main lesions was excluded from this analysis. Mean vessel reference diameter
was 2.590.45 mm and initial stenosis grade was 69.114.0%. To exclude a vaso-
motor tone effect a non-target vessel was evaluated as to the diameter change within
the observation period and from identical cine frames (n¼43). All PCIs were tech-
nically performed according to the recommendations of the German Consensus
Group.
Results: Minimal and mean lumina of the lesion and the treated segment increased
highly signiﬁcantly. The late lumen increase of the target lesion within the observation
period was 0.16 mm (1.750.58 vs 1.910.55 mm, p<0.05) and the diameter
stenosis was further reduced from 33.812.3 at end of index procedure to 26.913.8
% (p<0.05) at follow up angiography, while there were no changes in the vessel
diameter of the non target reference vessel (2.330.60 vs 2.340.61 mm, p ¼ n.s.).
No reintervention occurred in any of these patients, and MACE rate was 1.8%. There
was only 1 binary restenosis.
Conclusions: Local application of paclitaxel by drug-coated balloons to native
coronary arteries leads to late lumen enlargement in contrary to all other forms of PCI,
which all lead to LLL.
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Background: The classiﬁcation of patients using the appropriate use criteria (AUC)
for percutaneous coronary intervention (PCI) is growing, however the AUC are
criticized due to systematic and methodological issues. It is unclear to what extent
clinical outcomes may change based upon procedures classiﬁed as appropriate,
uncertain, or inappropriate.
Methods: Consecutive patients without acute coronary syndrome undergoing PCI at
multiple hospitals across the University of Pittsburgh Health System were enrolled in
a registry and followed prospectively since October 2011. Patient characteristics, in-
hospital events, and 6 month follow up were recorded. Using national guidelines,
cases were classiﬁed by the AUC criteria.
Results: A total of 442 cases were evaluated, among which 56.3% were Appropriate,
25.8% Uncertain, and 17.9% Inappropriate. There were no signiﬁcant differences with
regard to cardiovascular risk factors, except that patients classiﬁed as Appropriate
were more likely to have a prior history of myocardial infarction or bypass surgery.
Patients classiﬁed as Inappropriate were signiﬁcantly more likely to not have prior
stress testing (20.5% Appropriate vs. 53.2% Inappropriate, p<0.0001) and were more
likely to be asymptomatic. Cases classiﬁed as Inappropriate were signiﬁcantly more
likely to be pre-operative cases prior to non-cardiac surgery (9.6% Appropriate vs.
29.1% Inappropriate, p<0.0001). There were no differences in lesion and procedural
characteristics or signiﬁcant differences in the 6-month outcomes of death, myocardial
infarction, bleeding, in-stent thrombosis, or hospital readmission.
Conclusions: There are important characteristics of “Inappropriate” procedures that
may drive interventional cardiologists to perform these procedures; however, the AUC
do not allow for some factors to be considered in determining appropriateness. There
were no signiﬁcant differences in outcomes based upon AUC classiﬁcation. The AUC
criteria can be valuable but are limited and need to be reﬁned to incorporate important
factors that are often considered in routine clinical practice in the care of patients with
coronary artery disease.
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Cardiovascular Imaging Radiation in Coronary Artery Disease: Is It a Real
Concern?
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Background: The number of cardiac diagnostic and therapeutic procedures involving
ionizing radiation has increased rapidly in recent years, raising concerns about patients
(pts) radiation exposure. The annual pts effective radiation dose (ED) should not
exceed 1mSv, which is equivalent to 50 chest X-rays. We intend to estimate ED due to
cardiac diagnosis and therapeutic exams in pts with chronic coronary artery dis-
ease(CAD) during follow-up.
Methods: CAD outpatients of a tertiary hospital who had at least one cardiovascular
image exam were selected from 1999 to 2011. Patient evaluation of ED was
accomplished through literature standard values and multiplied by the number of testsber 1, 2013 j TCT Abstracts/POSTER/Miscellaneous Coronary Topics
Table 1. Characteristics of the study cohort
Total Male Female p value
420 310 (74) 110 (26)
Baseline characteristics:
Age (yr) 6511 6411 6612 0.098
Body Mass Index (kg/m2) 29.15.8 29.15.7 30.06.0 0.802
<25 88 (21) 22.91.9 22.42.1 0.215
25-30 172 (41) 27.31.4 27.21.4 0.690
>30 160 (38) 34.35.7 35.04.6 0.455
Body Surface Area (m2) 2.00.2 2.00.2 1.80.2 <0.0001
Diabetes Mellitus (%) 101 (24) 72 (23) 29 (26) 0.508
Prior CAG 26 (6) 19 (6) 7 (6) 0.930
Procedural characteristics:
Target-lesion SS 8.95.8 8.86.0 9.15.9 0.555
Radiation Dose (Gycm2) 872591 927612 718499 0.002
No of lesions 1.240.5 0.500.03 0.480.05 0.774
Indication
STEMI 100 76 (25) 24 (22) 0.643
Elective 163 123 (40) 40 (36) 0.540
Follow-on PCI 257 187 (60) 70 (64) 0.540
Fluoroscopy time (min) 20.228.9 19.022.1 23.642.7 0.161
Contrast volume (ml) 18671 18772 18367 0.617
Radial access (%) 7 (2) 5 (2) 2 (2) 0.885
No of stents per procedure 1.40.8 1.40.8 1.50.9 0.220
Total length of stents (mm) 29.020.3 28.719.4 29.922.8 0.598
Cine frame (n) 33.512.5 33.712.5 32.712.5 0.436
www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM
P
O
S
T
E
R
Sperformed. The ED assigned was 7mSv for left cardiac catheterization, 15mSv for
percutaneous coronary intervention and 9mSv for myocardial scintigraphy with ses-
tamibi. We also analyzed 196 consecutive exams in April 2013, including left cardiac
catheterization and percutaneous coronary intervention, to evaluate absorbed dose in
our institution.
Results: A total of 629 pts were included, mean age of 6211 years. In this cohort,
505(80%) pts performed at least one cardiac examination with radiation exposure,
with a mean of 2.62.9 examinations per patient (PP). ED estimation during an
average 4.83.6 years follow-up was 6634mSv, corresponding to 1312 patients
mSv/year, due to 0.66 cardiac catheterizations PP, 0.18 coronary interventions PP and
0.53 myocardial scintigraphy PP. Regarding our institution exams, the absorbed doses
were the following: 139 cardiac catheterizations (953.68 81.06 mGy) and 57
coronary interventions (1968.46250.41 mGy).
Conclusions: Data from our cohort demonstrates that pts with chronic CAD are
exposed to high levels of radiation due to cardiovascular imaging only. Considering
advances in this area, increasingly complex procedures performed and the widespread
use of screening radiological studies during a lifetime, it will be easy to go beyond
recommended limits of radiation exposure. Performance of any diagnostic test or
therapeutic procedure requires careful assessment of risks and beneﬁts and optimi-
zation of protocols to minimize patients and staff risks.
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Determinants of Residual Syntax Score after Primary Percutaneous Coronary
Intervention
Razi Khan1, Malek Al-Hawwas1, Raja Hatem1, Philippe L'Allier1, Hung Q. Ly1
1Montreal Heart Institute, Montreal, Quebec
Background: The SYNTAX score calculated after percutaneous intervention (PCI),
termed the residual SYNTAX score (RSS), has been shown to correlate with short-
and long-term outcomes in moderate-high risk acute coronary syndrome (ACS)
patients. The role of the RSS has not been studied in ST-elevation myocardial
infarction (STEMI) populations. Moreover, the completeness of revascularization in
the setting of multi-vessel disease in patients undergoing primary PCI (PPCI) is still
debated. Our study aim was to determine predictors of RSS using baseline charac-
teristics of patients undergoing PPCI.
Methods: The Montreal Heart Institute STEMI database was used for analyses.
Demographic, procedural and clinical data were collected prospectively.
Results: The last 100 consecutive patients undergoing PPCI were selected. Mean
patient age was 62.3+13.4 years old and patients were predominantly male (80%). The
mean RSS in the cohort was 4.34. Multi-vessel disease was associated with a higher
RSS than single-vessel disease (p<0.0001). Increased age, diabetes, admission
creatinine and history of chronic kidney disease (CKD) correlated with the RSS. The
average RSS in patients with and without diabetes were 7.2 and 3.7, respectively.
Mean RSS for patients with CKD was 17.7 compared with 3.6 without CKD.
Traditional risk factors for atherosclerotic disease, including male gender, hyperten-
sion, dyslipidemia, smoking history and family history of coronary disease, did not
correlate with RSS. A history of prior MI, PCI or congestive heart failure did not
impact RSS. Increased RSS was not associated with in-hospital clinical outcomes in
patients undergoing primary PCI. However, this may have been because there were
very few outcome events within this patient population. The SYNTAX score at
presentation was associated with higher TIMI thrombus grade severity in STEMI
patients prior to PPCI (p¼0.027).
Conclusions: Increased age, admission creatinine, CKD and diabetes predict RSS in
patients undergoing primary PCI. The impact of RSS on clinical outcomes in patients
undergoing PPCI requires further study from larger population cohorts.
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Impact of Gender on Radiation Dose from Percutaneous Coronary Intervention
of Similar Complexity Quantiﬁed by 'Target-lesion' SYNTAX Score
Leia Hee1, Manish Kumar1, Andrew Hopkins1, Liza Thomas1, Craig P. Juergens1,
Sidney Lo1, John K. French1, Christian J. Mussap1
1Liverpool Hospital, Sydney, NSW
Background: Radiation exposure is an adverse side effect of percutaneous coronary
intervention (PCI). The SYNTAX score quantiﬁes coronary lesion complexity. Our
hypothesis was that gender impacts on PCI radiation dose (RD) and procedural
characteristics.
Methods: We retrospectively studied 420 consecutive patients having PCI by six
experienced operators, at a single center (May-Dec 2011). The “target-lesion”
SYNTAX score (tSS) was used to quantify complexity of lesion(s) targeted for PCI.
tSS was the mean from two cardiologists scoring independently. Procedural charac-
teristics were extracted from a propriety database.
Results: Mean age was 6511yrs. Males (74%) had similar body mass index (BMI),
but greater body surface area (BSA), than females. There was no gender difference in
PCI procedural characteristics (Table 1). The mean RD was 872591Gycm2 and
mean tSS was 8.95.8. tSS was positively correlated with RD in both genders (Fig 1).
Males received signiﬁcantly higher RD than females, for PCI of comparable tSS.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Males receive signiﬁcantly higher RD than females in PCI of similar
complexity. Males have greater BSA (but similar BMI) than females, suggesting that
anthropometric indices impact on RD.
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Background: Small coronary vessels remain a lesion subset in which drug-eluting
stent (DES) remain associated with relatively high restenosis rates, especially in
diabetic patients. The aim of this study was to evaluate the efﬁcacy of drug-eluting
balloons (DEB) compared with paclitaxel-eluting stents (PES) for the reduction of
restenosis in diabetic patients with small vessels disease.acts/POSTER/Miscellaneous Coronary Topics B105
